Diagnosis of Glucocorticoid-Remediable Aldosteronism in Hypertensive Children
Autor: | Christine Haag, Christiane Maser-Gluth, Egbert Schulze, Clemens Kamrath |
---|---|
Rok vydání: | 2011 |
Předmět: |
Adult
Male medicine.medical_specialty Adolescent Hydrocortisone Endocrinology Diabetes and Metabolism Chimeric gene Plasma renin activity Dexamethasone chemistry.chemical_compound Endocrinology Primary aldosteronism Internal medicine Hyperaldosteronism Renin medicine Cytochrome P-450 CYP11B2 Humans Steroid 11-beta-hydroxylase Child Aldosterone Glucocorticoids Chimera business.industry Middle Aged medicine.disease Glucocorticoid remediable aldosteronism Pedigree chemistry Dexamethasone suppression test Hypertension Pediatrics Perinatology and Child Health Steroid 11-beta-Hydroxylase Female business medicine.drug |
Zdroj: | Hormone Research in Paediatrics. 76:93-98 |
ISSN: | 1663-2826 1663-2818 |
DOI: | 10.1159/000326524 |
Popis: | Objective: Glucocorticoid-remediable aldosteronism (GRA) is caused by the presence of a chimeric gene originating from an unequal cross-over between the CYP11B1 and CYP11B2 genes. Aldosterone suppression by dexamethasone and high 18-hydroxycortisol (18-OHF) levels have been used to differentiate GRA from the other forms of primary aldosteronism. Methods: A dexamethasone suppression test including serum 18-OHF determination and the measurement of urinary excretion of aldosterone, its metabolites and 18-OHF were performed in 3 children of a family with primary aldosteronism. Polymerase chain reactions were performed to identify the chimeric gene. Results: The chimeric gene was identified in 2 children, their mother and grandmother. The affected children had an aldosterone-to-plasma renin activity ratio >30, elevated serum 18-OHF concentration and increased urinary excretion of aldosterone, its metabolites, and 18-OHF. Post-dexamethasone concentrations of serum aldosterone and 18-OHF concentrations were suppressed. Conclusion: Although very rare, the possible diagnosis of GRA should be considered in all children or young adults with low-renin hypertension. Since genetic testing is more specific than biochemical testing, a definitive diagnosis can only be obtained by identification of the CYP11B1/CYP11B2 chimeric gene. |
Databáze: | OpenAIRE |
Externí odkaz: |